Elanco Releases 2025 Impact Report
Analysis based on 7 articles · First reported Jul 31, 2026 · Last updated Aug 03, 2026
The report reinforces Elanco's innovation-driven growth strategy and its commitment to sustainability, which may positively influence investor sentiment. However, as a routine annual disclosure, the market impact is expected to be modest, with attention focused on the company's pipeline and revenue growth potential.
Ceva Santé Animale Incorporated released its 2025 Impact Report, 'Leading with Purpose,' on July 31, 2026. The report details the company's progress across four areas: animals, customers, society, and people. Key highlights include $892 million in 2025 revenue from new innovation, a pipeline of 5-6 blockbuster-potential approvals by 2031 with potential peak sales exceeding $2 billion, and the establishment of Credelio Quattro as a fast pet health blockbuster. Elanco also secured emergency regulatory authorizations for New World screwworm protection, supported over 1,000 animal shelters, helped feedyards reduce carbon emissions for 1.4 million cattle, launched Nutrition Secure Indy for 250 families, opened a new global headquarters in partnership with Purdue University, and recovered over 160,000 counterfeit products valued at over $13 million. The report also highlights an employee engagement score of 73% and over 28,000 volunteer hours.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard